Survival Outcomes of Uterine Malignancies in Chinese Population

NCT03291275UNKNOWNOBSERVATIONAL

Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.

Key Facts

Lead Sponsor

Lei Li

Enrollment

10000

Start Date

2017-09-01

Completion Date

2022-09-01

Study Type

OBSERVATIONAL

Official Title

Survival Outcomes of Uterine Malignancies in Chinese Population

Interventions

Follow-up for death and recurrence

Conditions

Endometrial NeoplasmsSurvival

Eligibility

Sex

FEMALE

Inclusion Criteria:

* Primary uterine malignancies.

Exclusion Criteria:

* Metastatic malignancies to uterine corpus

Outcome Measures

Primary Outcomes

Overall survival

Survival duration from diagnosis to death

Time frame: 5 years

Progression-free survival

Survival duration from last treatment after remission to recurrence

Time frame: 5 years

Locations

Lei Li, Beijing, China

Linked Diseases

Endometrial Neoplasms

Endometrial Neoplasms — a type of gynecological cancer.

Survival Outcomes of Uterine Malignancies in Chinese Population